Meridian Bioscience to Present at the InvesTristate Regional Public Company Investment Conference

Meridian invites investors to listen to management's remarks, overthe Internet, on the Company's website at www.meridianbioscience.com.The link to the Conference is on the Investor Relations home page.

Meridian is a fully integrated life science company thatmanufactures, markets and distributes a broad range of innovativediagnostic test kits, purified reagents and related products andoffers biopharmaceutical enabling technologies. Utilizing a variety ofmethods, these products provide accuracy, simplicity and speed in theearly diagnosis and treatment of common medical conditions, such asgastrointestinal, viral, and respiratory infections. Meridiandiagnostic products are used outside of the human body and requirelittle or no special equipment. The Company's products are designed toenhance patient well-being while reducing the total outcome costs ofhealthcare. Meridian has strong market positions in the areas ofgastrointestinal and upper respiratory infections, serology,parasitology and fungal disease diagnosis. In addition, Meridian is asupplier of rare reagents and specialty biologicals along withproteins and other biologicals used by biopharmaceutical companiesengaged in research for new drugs and vaccines. The Company marketsits products to hospitals, reference laboratories, research centers,veterinary testing centers, physician offices and diagnosticsmanufacturers in more than 60 countries around the world. TheCompany's shares are traded through Nasdaq's National Market, symbolVIVO. Meridian's website address is www.meridianbioscience.com.